Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients

Transplantation

Volumn 64, Issue 2, 1997, Pages 281-286

  Stephan Breen, Catherine O ^a   Psaty, Bruce M ^a,b   Emerson, Scott ^b   Gretch, David ^b   Bronner, Mary ^b   Marsh, Christopher ^a   Davis, Connie L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DEATH; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVER FAILURE; MALE; PANCREAS TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS;

ADULT; BIOPSY; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LIVER; MALE; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030878795     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00018     Document Type: Article

References (47)

1. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359.
2. Kuo G, Choo Q, Alter H, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362.
3. Alter M, Margolis H, Krawczynski K, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899.
4. Tsai J, Chang W, Jeng J, Ho M, Lin Z, Tsai J. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98.
5. Tanaka H, Hiyama T, Tsukuma H, et al. Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data. Jpn J Cancer Res 1994; 85: 485.
6. DiBisceglie A, Order S, Klein J, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86: 335.
7. Giuberti T, Marin M, Ferrari C, et al. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 1994; 20: 666.
8. Gretch D, Wilson J, Corey L, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA PCR. high titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 1219.
9. Chan T, Lok A, Cheng I, Chan R. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5.
10. Gladziwa U, Schlipkoter U, Lorbeer B, Cholmakow K, Roggendorf M, Sieberth H. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis: a multicenter study. Clin Nephrol 1993; 40: 46.
11. Kuhns M, Medina M, McNamara A, et al. The detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 1994; 4: 1491.
12. Niu M, Coleman P, Alter M. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and staff. Am J Kidney Dis 1993: 22: 568.
13. Jankovic N, Cala S, Nadini'c B, Varlaj-Knobloch V, Pavlovi'c D. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up. Int J Artif Organs 1994; 17: 137.
14. Akpolat T, Arkin N, Arinsoy T, et al. High prevalence of antibodies to hepatitis C virus among renal transplant recipients: correlation with chronic liver dysfunction. Nephron 1993; 64: 163.
15. Morales J, Munoz M, Castellano C, et al. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. Transplantation 1993; 55: 1283.
16. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381.
17. Pol S, Legendre C, Saltiel C, et al. Hepatitis C virus in kidney transplant recipients: epidemiology and impact on renal transplantation. J Hepatol 1992; 15: 202.
18. Chan T, Lok A, Cheng I, Chan R. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993; 104: 862.
19. Vafiadis I, Boletis J, Papastathi H, et al. Hepatitis C virus infection among Greek renal transplant patients. Gut 1993; 34 (suppl 2): S57.
20. Fritsche C, Brandes J, Delaney S, et al. Hepatitis C virus is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283.
21. Cheng I, Chan D, Lok A. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. Transplant Proc 1993; 25: 1460.
22. Roth D, Fernandez J, Burke G, Esquenazi V, Miller J. Detection of antibody to hepatitis C virus in renal transplant recipients. Transplantation 1991; 51: 396.
23. Chan T, Lok A, Cheng I. Hepatitis C in renal transplant recipients. Transplantation 1991; 52: 810.
24. Pereira B. Hepatits C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens 1993; 2: 912.
25. Mahoney J. Long term results and complications of transplantation: the kidney. Transplant Proc 1989; 21: 1433.
26. Pereira B, Milford E, Kirkman R, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327: 910.
27. Aeder M, Shield C, Tegtmeier G, et al. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. Transplant Proc 1993; 25: 1469.
28. Roth D, Fernandez H, Babischkin S, et al. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Intern Med 1992; 117: 470.
29. Klauser R, Franz M, Traindl O, et al. Hepatitis C antibody in renal transplant patients. Transplant Proc 1992; 24: 286.
30. Stempel C, Lake J, Kuo G, Vincenti F. Hepatitis C: its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273.
31. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
32. Ynares C, Johnson H, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466.
33. Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992; 30: 2145.
34. Cox D. Regression models and life tables. J R Stat Soc 1972; 34: 187.
35. Ponz E, Comistol J, Bruguera M. Hepatitis C infection among kidney transplant recipients. Kidney Int 1991; 40: 748.
36. Valeri M, Pisani F, DePaolis P, et al. Hepatitis C virus infection in kidney transplant recipients. Transplant Proc 1993; 25: 2284.
37. Goffin E, Pirson Y, Cornu C, Geubel A, Squifflet J, van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int 1994; 45: 551.
38. Roth D, Zucker K, Cirocco R, et al. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996; 61: 886.
39. LaQuaglia M, Tolkoff-Rubin N, Dienstag J, et al. Impact of hepatitis on renal transplantation. Transplantation 1981; 28: 839.
40. Weir M, Kirkman R, Strom T, Tilsey N. Liver disease in recipients of long-functioning allografts. Kidney Int 1985; 28: 839.
41. Rao K, Anderson W, Kasiske B, Dahl D. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241.
42. Ware A, Luby J, Hollinger B, et al. Etiology of liver disease in renal-transplant patients. Ann Intern Med 1979; 91: 364.
43. Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097.
44. Pereira B, Wright T, Schmid C, Levey A. The impact of pretransplantation hepatitis C on the outcome of renal transplantation. Transplantation 1995; 60: 799.
45. Cohen G, Goffinet J, Donabedian R, Conn H. Observations on decreased serum glutamic oxaloacetic transaminases (SGOT) activity in azotemic patients. Ann Intern Med 1976; 84: 275.
46. Rumi M, Colombo M, Gringeri A, Mannucci P. High prevalence of antibody to hepatitis C virus in multitransfused haemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112: 379.
47. Chan T, Wu P, Lau J, Lai C, Lok A, Cheng I. Clinicopathologic features of hepatitis C virus infection in renal allograft recipients. Transplantation 1994; 58: 996.